LYPHOCHEK ENDOCRINE CONTROL - COFEPRIS Registration 1207R2018 SSA
Access comprehensive regulatory information for LYPHOCHEK ENDOCRINE CONTROL (LYPHOCHEK ENDOCRINE CONTROL) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1207R2018 SSA and manufactured by BIO-RAD, S.A.. The device was registered on May 28, 2018.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
LYPHOCHECK ENDOCRINE CONTROL TIENE UN USO INTENCIONADO COMO SUERO VALORADO PARA EL CONTROL DE LA CALIDAD CON EL FIN DE SUPERVISAR LA PRECISIÓN DE LOS PROCEDIMIENTOS DE ANÁLISIS DE LABORATORIO PARA LOS ANALITOS: DOPAMINA, EPINEFRINA Y NOREPINEFRINA
LYPHOCHECK ENDOCRINE CONTROL HAS AN INTENDED USE AS A SERUM RATED FOR QUALITY CONTROL IN ORDER TO MONITOR THE ACCURACY OF LABORATORY ANALYSIS PROCEDURES FOR ANALYTES: DOPAMINE, EPINEPHRINE AND NOREPINEPHRINE